{"id":"SCV000187678","clinical_assertion_trait_set_id":"SCV000187678","content":"{\"Citation\":[{\"@Type\":\"general\",\"ID\":{\"$\":\"25227144\",\"@Source\":\"PubMed\"}},{\"@Type\":\"general\",\"ID\":{\"$\":\"25227144\",\"@Source\":\"PubMed\"}}],\"Interpretation\":{\"Citation\":{\"@Type\":\"general\",\"ID\":{\"$\":\"25227144\",\"@Source\":\"PubMed\"}}}}","submission_id":"505267.2014-07-16","version":"1","internal_id":"339358","clinical_assertion_observation_ids":["SCV000187678.0"],"date_last_updated":"2020-04-18","assertion_type":"variation to disease","variation_archive_id":"VCV000003520","review_status":"no assertion criteria provided","trait_set_id":"6607","date_created":"2014-11-11","submitter_id":"505267","rcv_accession_id":"RCV000144921","submission_names":[],"local_key":"rs1801133","interpretation_comments":[],"record_status":"current","interpretation_description":"Uncertain significance","variation_id":"3520"}
{"id":"SCV000884146","clinical_assertion_trait_set_id":"SCV000884146","content":"{\"AttributeSet\":{\"Attribute\":{\"$\":\"ARUP Molecular Germline Variant Investigation Process\",\"@Type\":\"AssertionMethod\"},\"Citation\":{\"URL\":{\"$\":\"https://submit.ncbi.nlm.nih.gov/ft/byid/jucit10y/arup_molecular_germline_variant_investigation_process.pdf\"}}}}","submission_id":"25969.2019-08-05","interpretation_date_last_evaluated":"2018-07-13","version":"2","internal_id":"1730401","clinical_assertion_observation_ids":["SCV000884146.0"],"date_last_updated":"2020-04-18","assertion_type":"variation to disease","variation_archive_id":"VCV000003520","review_status":"criteria provided, single submitter","trait_set_id":"9590","date_created":"2019-02-15","submitter_id":"25969","rcv_accession_id":"RCV000428048","submission_names":["Aug 2019 ARUP"],"local_key":"74380|MedGen:CN169374","submitted_assembly":"not applicable","interpretation_comments":[],"record_status":"current","interpretation_description":"Uncertain significance","variation_id":"3520"}
{"id":"SCV000268236","clinical_assertion_trait_set_id":"SCV000268236","content":"{\"AttributeSet\":{\"Attribute\":{\"$\":\"Pharmacogenomics knowledge for personalized medicine\",\"@Type\":\"AssertionMethod\"},\"Citation\":{\"ID\":{\"$\":\"22992668\",\"@Source\":\"PubMed\"}}},\"Citation\":{\"URL\":{\"$\":\"https://www.pharmgkb.org/clinicalAnnotation/981204929\"}},\"Interpretation\":{\"Citation\":[{\"ID\":{\"$\":\"15051775\",\"@Source\":\"PubMed\"}},{\"ID\":{\"$\":\"19159907\",\"@Source\":\"PubMed\"}},{\"ID\":{\"$\":\"20638924\",\"@Source\":\"PubMed\"}}]}}","submission_id":"500295.2018-06-18","interpretation_date_last_evaluated":"2016-07-11","version":"3","internal_id":"503703","clinical_assertion_observation_ids":["SCV000268236.0"],"date_last_updated":"2020-04-18","assertion_type":"variation to disease","variation_archive_id":"VCV000003520","review_status":"reviewed by expert panel","trait_set_id":"26869","date_created":"2016-05-18","submitter_id":"500295","rcv_accession_id":"RCV000211133","submission_names":["PharmGKB-ClinVar 2018-05"],"local_key":"981204929PA449165|cyclophosphamide response - Toxicity/ADR","submitted_assembly":"GRCh38","interpretation_comments":["{\"text\":\"PharmGKB Level of Evidence 2A: Annotation for a variant-drug combination that qualifies for level 2B where the variant is within a VIP (Very Important Pharmacogene) as defined by PharmGKB. The variants in level 2A are in known pharmacogenes, so functional significance is more likely.\"}"],"record_status":"current","interpretation_description":"drug response","variation_id":"3520"}
{"id":"SCV000268238","clinical_assertion_trait_set_id":"SCV000268238","content":"{\"AttributeSet\":{\"Attribute\":{\"$\":\"Pharmacogenomics knowledge for personalized medicine\",\"@Type\":\"AssertionMethod\"},\"Citation\":{\"ID\":{\"$\":\"22992668\",\"@Source\":\"PubMed\"}}},\"Citation\":{\"URL\":{\"$\":\"https://www.pharmgkb.org/clinicalAnnotation/981220481\"}},\"Comment\":{\"$\":\"Drug is not necessarily used to treat response condition\"},\"Interpretation\":{\"Citation\":[{\"ID\":{\"$\":\"19307503\",\"@Source\":\"PubMed\"}},{\"ID\":{\"$\":\"21605004\",\"@Source\":\"PubMed\"}}]}}","submission_id":"500295.2018-06-18","interpretation_date_last_evaluated":"2016-07-11","version":"3","internal_id":"503705","clinical_assertion_observation_ids":["SCV000268238.0"],"date_last_updated":"2020-04-18","assertion_type":"variation to disease","variation_archive_id":"VCV000003520","review_status":"reviewed by expert panel","trait_set_id":"26870","date_created":"2016-05-18","submitter_id":"500295","rcv_accession_id":"RCV000211336","submission_names":["PharmGKB-ClinVar 2018-05"],"local_key":"981220481PA448803|carboplatin response - Efficacy","submitted_assembly":"GRCh38","interpretation_comments":["{\"text\":\"PharmGKB Level of Evidence 2A: Annotation for a variant-drug combination that qualifies for level 2B where the variant is within a VIP (Very Important Pharmacogene) as defined by PharmGKB. The variants in level 2A are in known pharmacogenes, so functional significance is more likely.\"}"],"record_status":"current","interpretation_description":"drug response","variation_id":"3520"}
{"id":"SCV000891532","clinical_assertion_trait_set_id":"SCV000891532","content":"{\"Interpretation\":{\"Citation\":{\"ID\":{\"$\":\"16432849\",\"@Source\":\"PubMed\"}}}}","submission_id":"506653.2018-10-25","interpretation_date_last_evaluated":"2017-12-30","version":"1","internal_id":"1747332","clinical_assertion_observation_ids":["SCV000891532.0"],"date_last_updated":"2020-04-18","assertion_type":"variation to disease","variation_archive_id":"VCV000003520","review_status":"no assertion criteria provided","trait_set_id":"6404","date_created":"2019-03-21","submitter_id":"506653","rcv_accession_id":"RCV000761447","submission_names":["SUB4684823"],"local_key":"NM_005957.4:c.665C\u003eT|OMIM:188050","submitted_assembly":"GRCh37","interpretation_comments":[],"record_status":"current","interpretation_description":"Uncertain significance","variation_id":"3520"}
{"id":"SCV000494694","clinical_assertion_trait_set_id":"SCV000494694","content":"{\"AttributeSet\":{\"Attribute\":{\"$\":\"Pharmacogenomics knowledge for personalized medicine\",\"@Type\":\"AssertionMethod\"},\"Citation\":{\"ID\":{\"$\":\"22992668\",\"@Source\":\"PubMed\"}}},\"Citation\":{\"URL\":{\"$\":\"https://www.pharmgkb.org/clinicalAnnotation/827848365\"}},\"Comment\":{\"$\":\"Drug is not necessarily used to treat response condition\"},\"Interpretation\":{\"Citation\":[{\"ID\":{\"$\":\"11418485\",\"@Source\":\"PubMed\"}},{\"ID\":{\"$\":\"12453860\",\"@Source\":\"PubMed\"}},{\"ID\":{\"$\":\"12915598\",\"@Source\":\"PubMed\"}},{\"ID\":{\"$\":\"14647408\",\"@Source\":\"PubMed\"}},{\"ID\":{\"$\":\"15051775\",\"@Source\":\"PubMed\"}},{\"ID\":{\"$\":\"15781665\",\"@Source\":\"PubMed\"}},{\"ID\":{\"$\":\"16013960\",\"@Source\":\"PubMed\"}},{\"ID\":{\"$\":\"16019535\",\"@Source\":\"PubMed\"}},{\"ID\":{\"$\":\"16462575\",\"@Source\":\"PubMed\"}},{\"ID\":{\"$\":\"16463153\",\"@Source\":\"PubMed\"}},{\"ID\":{\"$\":\"16501586\",\"@Source\":\"PubMed\"}},{\"ID\":{\"$\":\"16870553\",\"@Source\":\"PubMed\"}},{\"ID\":{\"$\":\"17180579\",\"@Source\":\"PubMed\"}},{\"ID\":{\"$\":\"17323057\",\"@Source\":\"PubMed\"}},{\"ID\":{\"$\":\"17488658\",\"@Source\":\"PubMed\"}},{\"ID\":{\"$\":\"17512587\",\"@Source\":\"PubMed\"}},{\"ID\":{\"$\":\"18458567\",\"@Source\":\"PubMed\"}},{\"ID\":{\"$\":\"18987660\",\"@Source\":\"PubMed\"}},{\"ID\":{\"$\":\"19159907\",\"@Source\":\"PubMed\"}},{\"ID\":{\"$\":\"19648163\",\"@Source\":\"PubMed\"}},{\"ID\":{\"$\":\"21644011\",\"@Source\":\"PubMed\"}},{\"ID\":{\"$\":\"21747412\",\"@Source\":\"PubMed\"}},{\"ID\":{\"$\":\"22143415\",\"@Source\":\"PubMed\"}},{\"ID\":{\"$\":\"22838948\",\"@Source\":\"PubMed\"}},{\"ID\":{\"$\":\"23089671\",\"@Source\":\"PubMed\"}},{\"ID\":{\"$\":\"23488607\",\"@Source\":\"PubMed\"}},{\"ID\":{\"$\":\"23648444\",\"@Source\":\"PubMed\"}},{\"ID\":{\"$\":\"23775025\",\"@Source\":\"PubMed\"}},{\"ID\":{\"$\":\"24241962\",\"@Source\":\"PubMed\"}},{\"ID\":{\"$\":\"24637499\",\"@Source\":\"PubMed\"}},{\"ID\":{\"$\":\"25007187\",\"@Source\":\"PubMed\"}},{\"ID\":{\"$\":\"25065700\",\"@Source\":\"PubMed\"}},{\"ID\":{\"$\":\"25110820\",\"@Source\":\"PubMed\"}},{\"ID\":{\"$\":\"25303299\",\"@Source\":\"PubMed\"}},{\"ID\":{\"$\":\"25778468\",\"@Source\":\"PubMed\"}},{\"ID\":{\"$\":\"26014925\",\"@Source\":\"PubMed\"}},{\"ID\":{\"$\":\"27399166\",\"@Source\":\"PubMed\"}},{\"ID\":{\"$\":\"28696419\",\"@Source\":\"PubMed\"}},{\"ID\":{\"$\":\"29683944\",\"@Source\":\"PubMed\"}}]}}","submission_id":"500295.2018-06-18","interpretation_date_last_evaluated":"2018-05-14","version":"2","internal_id":"967913","clinical_assertion_observation_ids":["SCV000494694.0"],"date_last_updated":"2020-04-18","assertion_type":"variation to disease","variation_archive_id":"VCV000003520","review_status":"reviewed by expert panel","trait_set_id":"35046","date_created":"2017-02-17","submitter_id":"500295","rcv_accession_id":"RCV000417131","submission_names":["PharmGKB-ClinVar 2018-05"],"local_key":"827848365PA450428|methotrexate response - Dosage, Efficacy, Toxicity/ADR","submitted_assembly":"GRCh38","interpretation_comments":["{\"text\":\"PharmGKB Level of Evidence 2A: Annotation for a variant-drug combination that qualifies for level 2B where the variant is within a VIP (Very Important Pharmacogene) as defined by PharmGKB. The variants in level 2A are in known pharmacogenes, so functional significance is more likely.\"}"],"record_status":"current","interpretation_description":"drug response","variation_id":"3520"}
{"id":"SCV000505736","clinical_assertion_trait_set_id":"SCV000505736","content":"{\"AttributeSet\":{\"Attribute\":{\"$\":\"Somatic mutation\",\"@Type\":\"ModeOfInheritance\"}},\"Citation\":{\"URL\":{\"$\":\"http://docm.genome.wustl.edu/variants/ENST00000376592:c.665C\u003eT\"}},\"Interpretation\":{\"Citation\":{\"ID\":{\"$\":\"18704422\",\"@Source\":\"PubMed\"}}},\"StudyDescription\":{\"$\":\"This is the initial submission of DoCM to ClinVar. DoCM is the database of curated mutations in cancer and seeks to leverage the community to outline all functionally important somatic cancer variants in the literature.\"}}","submission_id":"505871.2016-07-18","interpretation_date_last_evaluated":"2016-03-10","version":"1","internal_id":"971011","clinical_assertion_observation_ids":["SCV000505736.0"],"date_last_updated":"2020-04-18","assertion_type":"variation to disease","variation_archive_id":"VCV000003520","review_status":"no assertion provided","trait_set_id":"6728","date_created":"2017-03-02","submitter_id":"505871","rcv_accession_id":"RCV000427078","submission_names":["DoCM_7-13-16"],"local_key":"ENST00000376592:c.665C\u003eT|MeSH:D013274","submitted_assembly":"GRCh37","interpretation_comments":[],"record_status":"current","interpretation_description":"not provided","variation_id":"3520"}
{"id":"SCV000519504","clinical_assertion_trait_set_id":"SCV000519504","content":"{\"AttributeSet\":{\"Attribute\":{\"$\":\"GeneDX Variant Classification (06012015)\",\"@Type\":\"AssertionMethod\"},\"Citation\":{\"URL\":{\"$\":\"https://submit.ncbi.nlm.nih.gov/ft/byid/7oynscmk/mdi-5616_26957_genedx_interprules_final_061215.pdf\"}}}}","submission_id":"26957.2018-03-26","interpretation_date_last_evaluated":"2016-04-25","version":"4","internal_id":"984917","clinical_assertion_observation_ids":["SCV000519504.0"],"date_last_updated":"2020-04-18","assertion_type":"variation to disease","variation_archive_id":"VCV000003520","review_status":"criteria provided, single submitter","trait_set_id":"9590","date_created":"2017-03-03","submitter_id":"26957","rcv_accession_id":"RCV000428048","submission_names":["SUB3839901"],"local_key":"GDX:570299|Not Provided","submitted_assembly":"GRCh37","interpretation_comments":["{\"text\":\"This variant is considered likely benign or benign based on one or more of the following criteria: it is a conservative change, it occurs at a poorly conserved position in the protein, it is predicted to be benign by multiple in silico algorithms, and/or has population frequency not consistent with disease.\"}"],"record_status":"current","interpretation_description":"Benign","variation_id":"3520"}
{"id":"SCV000203040","clinical_assertion_trait_set_id":"SCV000203040","content":"{\"AttributeSet\":{\"Attribute\":{\"$\":\"EGL_Classification_Definitions_2015\",\"@Type\":\"AssertionMethod\"},\"Citation\":{\"URL\":{\"$\":\"https://submit.ncbi.nlm.nih.gov/ft/byid/dn5yhybg/egl_classification_definitions_2015.pdf\"}}},\"Citation\":{\"URL\":{\"$\":\"http://www.egl-eurofins.com/emvclass/emvclass.php?approved_symbol=MTHFR\"}},\"ClinVarSubmissionID\":{\"@localKeyIsSubmitted\":\"1\"}}","submission_id":"500060.2018-09-19","interpretation_date_last_evaluated":"2017-01-13","version":"7","internal_id":"361011","clinical_assertion_observation_ids":["SCV000203040.0"],"date_last_updated":"2020-04-18","assertion_type":"variation to disease","variation_archive_id":"VCV000003520","review_status":"criteria provided, single submitter","trait_set_id":"9460","date_created":"2015-01-28","submitter_id":"500060","rcv_accession_id":"RCV000153516","submission_names":["SUB4534263"],"local_key":"8162_000000","submitted_assembly":"GRCh37","interpretation_comments":[],"record_status":"current","interpretation_description":"other","variation_id":"3520"}
{"id":"SCV001135171","clinical_assertion_trait_set_id":"SCV001135171","content":"{\"AttributeSet\":{\"Attribute\":{\"$\":\"Mendelics Assertion Criteria 2017\",\"@Type\":\"AssertionMethod\"},\"Citation\":{\"URL\":{\"$\":\"https://submit.ncbi.nlm.nih.gov/ft/byid/chhjzatu/mendelics_assertion_criteria_2017.pdf\"}}}}","submission_id":"500035.2019-10-22","interpretation_date_last_evaluated":"2019-05-28","version":"1","internal_id":"2240970","clinical_assertion_observation_ids":["SCV001135171.0"],"date_last_updated":"2020-04-18","assertion_type":"variation to disease","variation_archive_id":"VCV000003520","review_status":"criteria provided, single submitter","trait_set_id":"6564","date_created":"2020-01-07","submitter_id":"500035","rcv_accession_id":"RCV000259890","submission_names":["MENDELICS_CLINVAR_020"],"local_key":"NC_000001.10:g.11856378G\u003eA|OMIM:601634","submitted_assembly":"GRCh37","interpretation_comments":[],"record_status":"current","interpretation_description":"Likely benign","variation_id":"3520"}
{"id":"SCV001147149","clinical_assertion_trait_set_id":"SCV001147149","content":"{\"AttributeSet\":{\"Attribute\":{\"$\":\"Praxis fuer Humangenetik Tuebingen - Variant Classification Criteria\",\"@Type\":\"AssertionMethod\"},\"Citation\":{\"URL\":{\"$\":\"https://submit.ncbi.nlm.nih.gov/ft/byid/TbQpmFtg/PHGTv1.pdf\"}}}}","submission_id":"505870.2019-07-12","interpretation_date_last_evaluated":"2016-10-01","version":"1","internal_id":"2265337","clinical_assertion_observation_ids":["SCV001147149.0"],"date_last_updated":"2020-04-18","assertion_type":"variation to disease","variation_archive_id":"VCV000003520","review_status":"criteria provided, single submitter","trait_set_id":"9460","date_created":"2020-01-30","submitter_id":"505870","rcv_accession_id":"RCV000153516","submission_names":["2019-07"],"local_key":":Chr.1_11856378_11856378_G_A|MedGen:CN517202","submitted_assembly":"GRCh37","interpretation_comments":[],"record_status":"current","interpretation_description":"Uncertain significance","variation_id":"3520"}
{"id":"SCV000023860","clinical_assertion_trait_set_id":"SCV000023860","submission_id":"3.2015-03-10","interpretation_date_last_evaluated":"2019-06-11","version":"6","internal_id":"23860","clinical_assertion_observation_ids":["SCV000023860.0"],"date_last_updated":"2020-04-18","assertion_type":"variation to disease","variation_archive_id":"VCV000003520","review_status":"no assertion criteria provided","title":"MTHFR, 677C-T, ALA222VAL (rs1801133)_MTHFR THERMOLABILE POLYMORPHISM","trait_set_id":"916","date_created":"2011-01-25","submitter_id":"3","rcv_accession_id":"RCV000003697","submission_names":[],"local_key":"607093.0003_MTHFR THERMOLABILE POLYMORPHISM","interpretation_comments":[],"record_status":"current","interpretation_description":"Benign","variation_id":"3520"}
{"id":"SCV000106043","clinical_assertion_trait_set_id":"SCV000106043","submission_id":"256489.2017-03-08","version":"1","internal_id":"183447","clinical_assertion_observation_ids":["SCV000106043.0"],"date_last_updated":"2020-04-18","assertion_type":"variation to disease","variation_archive_id":"VCV000003520","review_status":"no assertion criteria provided","trait_set_id":"916","date_created":"2013-11-19","submitter_id":"256489","rcv_accession_id":"RCV000003697","submission_names":["FirmaLab_clinical_tests_from_GTR"],"local_key":"NM_005957.4:c.665C\u003eT|MedGen:C1856059","submitted_assembly":"not applicable","interpretation_comments":[],"record_status":"current","interpretation_description":"Pathogenic","variation_id":"3520"}
{"id":"SCV000347807","clinical_assertion_trait_set_id":"SCV000347807","content":"{\"AttributeSet\":{\"Attribute\":{\"$\":\"ICSL Variant Classification 20161018\",\"@Type\":\"AssertionMethod\"},\"Citation\":{\"@Type\":\"general\",\"CitationText\":{\"$\":\"ICSL_Variant_Classification_20161018.pdf\"},\"URL\":{\"$\":\"https://submit.ncbi.nlm.nih.gov/ft/byid/4jQgNGYk/ICSL_Variant_Classification_20161018.pdf\"}}}}","submission_id":"504895.2016-10-18","interpretation_date_last_evaluated":"2016-06-14","version":"2","internal_id":"661330","clinical_assertion_observation_ids":["SCV000347807.0"],"date_last_updated":"2020-04-18","assertion_type":"variation to disease","variation_archive_id":"VCV000003520","review_status":"criteria provided, single submitter","trait_set_id":"6564","date_created":"2016-12-02","submitter_id":"504895","rcv_accession_id":"RCV000259890","submission_names":["ICSL_2016Q4"],"local_key":"361|Neural Tube Defects, Folate-Sensitive","submitted_assembly":"GRCh37","interpretation_comments":[],"record_status":"current","interpretation_description":"Likely benign","variation_id":"3520"}
{"id":"SCV000549301","clinical_assertion_trait_set_id":"SCV000549301","content":"{\"AttributeSet\":{\"Attribute\":{\"$\":\"Invitae Variant Classification Sherloc (09022015)\",\"@Type\":\"AssertionMethod\"},\"Citation\":{\"ID\":{\"$\":\"28492532\",\"@Source\":\"PubMed\"}}},\"Citation\":{\"@Type\":\"general\",\"ID\":{\"$\":\"28492532\",\"@Source\":\"PubMed\"}}}","submission_id":"500031.2020-02-06","interpretation_date_last_evaluated":"2019-11-25","version":"6","internal_id":"1062197","clinical_assertion_observation_ids":["SCV000549301.0"],"date_last_updated":"2020-04-15","assertion_type":"variation to disease","variation_archive_id":"VCV000037594","review_status":"criteria provided, single submitter","trait_set_id":"7920","date_created":"2017-04-13","submitter_id":"500031","rcv_accession_id":"RCV000458634","submission_names":["SUB6933778"],"local_key":"676082|MedGen:C0677776","submitted_assembly":"GRCh37","interpretation_comments":[],"record_status":"current","interpretation_description":"Likely benign","variation_id":"37594"}
{"id":"SCV001119032","clinical_assertion_trait_set_id":"SCV001119032","content":"{\"AttributeSet\":{\"Attribute\":{\"$\":\"Invitae Variant Classification Sherloc (09022015)\",\"@Type\":\"AssertionMethod\"},\"Citation\":{\"ID\":{\"$\":\"28492532\",\"@Source\":\"PubMed\"}}}}","submission_id":"500031.2020-01-29","interpretation_date_last_evaluated":"2019-12-31","version":"2","internal_id":"2086965","clinical_assertion_observation_ids":["SCV001119032.0"],"date_last_updated":"2020-05-04","assertion_type":"variation to disease","variation_archive_id":"VCV000046503","review_status":"criteria provided, single submitter","trait_set_id":"9460","date_created":"2019-12-14","submitter_id":"500031","rcv_accession_id":"RCV000727222","submission_names":["SUB6897608"],"local_key":"2035389|MedGen:CN517202","submitted_assembly":"GRCh37","interpretation_comments":[],"record_status":"current","interpretation_description":"Benign","variation_id":"46503"}
{"id":"SCV001144884","clinical_assertion_trait_set_id":"SCV001144884","content":"{\"AttributeSet\":{\"Attribute\":{\"$\":\"Athena Diagnostics Criteria\",\"@Type\":\"AssertionMethod\"},\"Citation\":{\"ID\":{\"$\":\"26467025\",\"@Source\":\"PubMed\"}}},\"Interpretation\":{\"Citation\":{\"ID\":{\"$\":\"27208204\",\"@Source\":\"PubMed\"}}}}","submission_id":"1012.2019-09-25","interpretation_date_last_evaluated":"2019-03-14","version":"1","internal_id":"2256633","clinical_assertion_observation_ids":["SCV001144884.0"],"date_last_updated":"2020-04-18","assertion_type":"variation to disease","variation_archive_id":"VCV000046503","review_status":"criteria provided, single submitter","trait_set_id":"9460","date_created":"2020-01-16","submitter_id":"1012","rcv_accession_id":"RCV000727222","submission_names":["SUB6347501"],"local_key":"2853148|not provided","submitted_assembly":"GRCh37","interpretation_comments":[],"record_status":"current","interpretation_description":"Likely benign","variation_id":"46503"}
{"id":"SCV001157178","clinical_assertion_trait_set_id":"SCV001157178","content":"{\"AttributeSet\":{\"Attribute\":{\"$\":\"ARUP Molecular Germline Variant Investigation Process\",\"@Type\":\"AssertionMethod\"},\"Citation\":{\"URL\":{\"$\":\"https://submit.ncbi.nlm.nih.gov/ft/byid/jucit10y/arup_molecular_germline_variant_investigation_process.pdf\"}}}}","submission_id":"25969.2019-08-05","interpretation_date_last_evaluated":"2019-06-26","version":"1","internal_id":"2281510","clinical_assertion_observation_ids":["SCV001157178.0"],"date_last_updated":"2020-04-18","assertion_type":"variation to disease","variation_archive_id":"VCV000046503","review_status":"criteria provided, single submitter","trait_set_id":"9590","date_created":"2020-02-07","submitter_id":"25969","rcv_accession_id":"RCV000039762","submission_names":["Aug 2019 ARUP"],"local_key":"121670|MedGen:CN169374","submitted_assembly":"not applicable","interpretation_comments":[],"record_status":"current","interpretation_description":"Benign","variation_id":"46503"}
{"id":"SCV000063451","clinical_assertion_trait_set_id":"SCV000063451","content":"{\"AttributeSet\":{\"Attribute\":{\"$\":\"LMM Criteria\",\"@Type\":\"AssertionMethod\"},\"Citation\":{\"ID\":{\"$\":\"24033266\",\"@Source\":\"PubMed\"}}}}","submission_id":"21766.2019-03-21","interpretation_date_last_evaluated":"2017-09-04","version":"6","internal_id":"104651","clinical_assertion_observation_ids":["SCV000063451.0"],"date_last_updated":"2020-04-18","assertion_type":"variation to disease","variation_archive_id":"VCV000046503","review_status":"criteria provided, single submitter","trait_set_id":"9590","date_created":"2013-03-16","submitter_id":"21766","rcv_accession_id":"RCV000039762","submission_names":["SUB5348979"],"local_key":"30968208|not specified","submitted_assembly":"GRCh37","interpretation_comments":["{\"text\":\"p.Ala1855Ala in exon 33 of PCDH15: This variant is not expected to have clinical significance because it does not alter an amino acid residue, is not located ne ar a splice junction and has been identified in 0.3% (381/126618) European chro mosomes by the Genome Aggregation Database (gnomAD, http://gnomad.broadinstitute .org; dbSNP rs111033445).\"}"],"record_status":"current","interpretation_description":"Likely benign","variation_id":"46503"}
{"id":"SCV000706730","clinical_assertion_trait_set_id":"SCV000706730","content":"{\"AttributeSet\":{\"Attribute\":{\"$\":\"EGL_ClinVar_v180209_classification definitions\",\"@Type\":\"AssertionMethod\"},\"Citation\":{\"URL\":{\"$\":\"https://submit.ncbi.nlm.nih.gov/ft/byid/leconafi/egl_clinvar_v180209_classification_definitions.pdf\"}}},\"Citation\":{\"URL\":{\"$\":\"http://www.egl-eurofins.com/emvclass/emvclass.php?approved_symbol=PCDH15\"}},\"ClinVarSubmissionID\":{\"@localKeyIsSubmitted\":\"1\"}}","submission_id":"500060.2018-09-19","interpretation_date_last_evaluated":"2018-05-30","version":"2","internal_id":"1379128","clinical_assertion_observation_ids":["SCV000706730.0"],"date_last_updated":"2020-04-18","assertion_type":"variation to disease","variation_archive_id":"VCV000046503","review_status":"criteria provided, single submitter","trait_set_id":"9460","date_created":"2018-03-28","submitter_id":"500060","rcv_accession_id":"RCV000727222","submission_names":["SUB4534263"],"local_key":"60128_000000","submitted_assembly":"GRCh37","interpretation_comments":[],"record_status":"current","interpretation_description":"Uncertain significance","variation_id":"46503"}
{"id":"SCV000729392","clinical_assertion_trait_set_id":"SCV000729392","content":"{\"AttributeSet\":{\"Attribute\":{\"$\":\"GeneDX Variant Classification (06012015)\",\"@Type\":\"AssertionMethod\"},\"Citation\":{\"URL\":{\"$\":\"https://submit.ncbi.nlm.nih.gov/ft/byid/7oynscmk/mdi-5616_26957_genedx_interprules_final_061215.pdf\"}}}}","submission_id":"26957.2018-03-26","interpretation_date_last_evaluated":"2017-11-21","version":"1","internal_id":"1410550","clinical_assertion_observation_ids":["SCV000729392.0"],"date_last_updated":"2020-04-18","assertion_type":"variation to disease","variation_archive_id":"VCV000046503","review_status":"criteria provided, single submitter","trait_set_id":"9590","date_created":"2018-04-04","submitter_id":"26957","rcv_accession_id":"RCV000039762","submission_names":["SUB3839901"],"local_key":"GDX:46979|Not Provided","submitted_assembly":"GRCh37","interpretation_comments":["{\"text\":\"This variant is considered likely benign or benign based on one or more of the following criteria: it is a conservative change, it occurs at a poorly conserved position in the protein, it is predicted to be benign by multiple in silico algorithms, and/or has population frequency not consistent with disease.\"}"],"record_status":"current","interpretation_description":"Likely benign","variation_id":"46503"}
{"id":"SCV000363106","clinical_assertion_trait_set_id":"SCV000363106","content":"{\"AttributeSet\":{\"Attribute\":{\"$\":\"ICSL Variant Classification 20161018\",\"@Type\":\"AssertionMethod\"},\"Citation\":{\"@Type\":\"general\",\"CitationText\":{\"$\":\"ICSL_Variant_Classification_20161018.pdf\"},\"URL\":{\"$\":\"https://submit.ncbi.nlm.nih.gov/ft/byid/4jQgNGYk/ICSL_Variant_Classification_20161018.pdf\"}}}}","submission_id":"504895.2016-10-18","interpretation_date_last_evaluated":"2016-06-14","version":"2","internal_id":"676628","clinical_assertion_observation_ids":["SCV000363106.0"],"date_last_updated":"2020-04-18","assertion_type":"variation to disease","variation_archive_id":"VCV000046503","review_status":"criteria provided, single submitter","trait_set_id":"33370","date_created":"2016-12-02","submitter_id":"504895","rcv_accession_id":"RCV000326661","submission_names":["ICSL_2016Q4"],"local_key":"165026|Nonsyndromic Hearing Loss, Recessive","submitted_assembly":"GRCh37","interpretation_comments":[],"record_status":"current","interpretation_description":"Uncertain significance","variation_id":"46503"}
{"id":"SCV000363107","clinical_assertion_trait_set_id":"SCV000363107","content":"{\"AttributeSet\":{\"Attribute\":{\"$\":\"ICSL Variant Classification 20161018\",\"@Type\":\"AssertionMethod\"},\"Citation\":{\"@Type\":\"general\",\"CitationText\":{\"$\":\"ICSL_Variant_Classification_20161018.pdf\"},\"URL\":{\"$\":\"https://submit.ncbi.nlm.nih.gov/ft/byid/4jQgNGYk/ICSL_Variant_Classification_20161018.pdf\"}}}}","submission_id":"504895.2016-10-18","interpretation_date_last_evaluated":"2016-06-14","version":"2","internal_id":"676629","clinical_assertion_observation_ids":["SCV000363107.0"],"date_last_updated":"2020-04-18","assertion_type":"variation to disease","variation_archive_id":"VCV000046503","review_status":"criteria provided, single submitter","date_created":"2016-12-02","submitter_id":"504895","submission_names":["ICSL_2016Q4"],"local_key":"165026|Usher Syndrome","submitted_assembly":"GRCh37","interpretation_comments":[],"record_status":"current","interpretation_description":"Uncertain significance","variation_id":"46503"}
{"id":"SCV001144806","clinical_assertion_trait_set_id":"SCV001144806","content":"{\"AttributeSet\":{\"Attribute\":{\"$\":\"Athena Diagnostics Criteria\",\"@Type\":\"AssertionMethod\"},\"Citation\":{\"ID\":{\"$\":\"26467025\",\"@Source\":\"PubMed\"}}},\"Interpretation\":{\"Citation\":[{\"ID\":{\"$\":\"27068579\",\"@Source\":\"PubMed\"}},{\"ID\":{\"$\":\"20146813\",\"@Source\":\"PubMed\"}}]}}","submission_id":"1012.2019-09-25","interpretation_date_last_evaluated":"2019-05-14","version":"1","internal_id":"2256555","clinical_assertion_observation_ids":["SCV001144806.0"],"date_last_updated":"2020-04-18","assertion_type":"variation to disease","variation_archive_id":"VCV000048176","review_status":"criteria provided, single submitter","trait_set_id":"9460","date_created":"2020-01-16","submitter_id":"1012","rcv_accession_id":"RCV000726979","submission_names":["SUB6347501"],"local_key":"2854484|not provided","submitted_assembly":"GRCh37","interpretation_comments":[],"record_status":"current","interpretation_description":"Uncertain significance","variation_id":"48176"}
{"id":"SCV000065162","clinical_assertion_trait_set_id":"SCV000065162","content":"{\"AttributeSet\":{\"Attribute\":{\"$\":\"LMM Criteria\",\"@Type\":\"AssertionMethod\"},\"Citation\":{\"ID\":{\"$\":\"24033266\",\"@Source\":\"PubMed\"}}},\"Interpretation\":{\"Citation\":{\"ID\":{\"$\":\"27068579\",\"@Source\":\"PubMed\"}}}}","submission_id":"21766.2019-03-21","interpretation_date_last_evaluated":"2018-08-21","version":"6","internal_id":"106362","clinical_assertion_observation_ids":["SCV000065162.0"],"date_last_updated":"2020-04-18","assertion_type":"variation to disease","variation_archive_id":"VCV000048176","review_status":"criteria provided, single submitter","trait_set_id":"9590","date_created":"2013-03-16","submitter_id":"21766","rcv_accession_id":"RCV000041467","submission_names":["SUB5348979"],"local_key":"11832988|not specified","submitted_assembly":"GRCh37","interpretation_comments":["{\"text\":\"The p.Arg544Cys variant in OTOF has been identified in 1 individual with autosom al recessive sensorineural hearing loss who carried a second OTOF variant of unc ertain significance; it is unclear whether these variants are in trans (Sommen 2 016). The p.Arg544Cys variant has also been identified by our laboratory in 6 in dividuals with hearing loss; however, none of these individuals carried a varian t affecting the other copy of the OTOF gene or was reported to have auditory neu ropathy typically associated with OTOF related hearing loss. This variant has be en reported in ClinVar (Variation ID: 48176). It has been identified in 0.15% (1 93/125430) of European chromosomes by the Genome Aggregation Database (gnomAD, h ttp://gnomad.broadinstitute.org); however, this frequency is not high enough to rule out a pathogenic role. Computational prediction tools and conservation anal ysis suggest that the p.Arg544Cys variant may impact the protein, though this in formation is not predictive enough to determine pathogenicity. In summary, the c linical significance of the p.Arg544Cys variant is uncertain. ACMG/AMP Criteria applied: PP3, BS1_Supporting.\"}"],"record_status":"current","interpretation_description":"Uncertain significance","variation_id":"48176"}
{"id":"SCV000704632","clinical_assertion_trait_set_id":"SCV000704632","content":"{\"AttributeSet\":{\"Attribute\":{\"$\":\"EGL_Classification_Definitions_2015\",\"@Type\":\"AssertionMethod\"},\"Citation\":{\"URL\":{\"$\":\"https://submit.ncbi.nlm.nih.gov/ft/byid/dn5yhybg/egl_classification_definitions_2015.pdf\"}}},\"Citation\":{\"URL\":{\"$\":\"http://www.egl-eurofins.com/emvclass/emvclass.php?approved_symbol=OTOF\"}},\"ClinVarSubmissionID\":{\"@localKeyIsSubmitted\":\"1\"}}","submission_id":"500060.2018-09-19","interpretation_date_last_evaluated":"2016-12-20","version":"2","internal_id":"1377031","clinical_assertion_observation_ids":["SCV000704632.0"],"date_last_updated":"2020-04-18","assertion_type":"variation to disease","variation_archive_id":"VCV000048176","review_status":"criteria provided, single submitter","trait_set_id":"9460","date_created":"2018-03-28","submitter_id":"500060","rcv_accession_id":"RCV000726979","submission_names":["SUB4534263"],"local_key":"57851_000000","submitted_assembly":"GRCh37","interpretation_comments":[],"record_status":"current","interpretation_description":"Uncertain significance","variation_id":"48176"}
{"id":"SCV000429634","clinical_assertion_trait_set_id":"SCV000429634","content":"{\"AttributeSet\":{\"Attribute\":{\"$\":\"ICSL Variant Classification 20161018\",\"@Type\":\"AssertionMethod\"},\"Citation\":{\"@Type\":\"general\",\"CitationText\":{\"$\":\"ICSL_Variant_Classification_20161018.pdf\"},\"URL\":{\"$\":\"https://submit.ncbi.nlm.nih.gov/ft/byid/4jQgNGYk/ICSL_Variant_Classification_20161018.pdf\"}}}}","submission_id":"504895.2016-10-18","interpretation_date_last_evaluated":"2016-06-14","version":"2","internal_id":"743155","clinical_assertion_observation_ids":["SCV000429634.0"],"date_last_updated":"2020-04-18","assertion_type":"variation to disease","variation_archive_id":"VCV000048176","review_status":"criteria provided, single submitter","trait_set_id":"33370","date_created":"2016-12-02","submitter_id":"504895","rcv_accession_id":"RCV000357820","submission_names":["ICSL_2016Q4"],"local_key":"231996|Nonsyndromic Hearing Loss, Recessive","submitted_assembly":"GRCh37","interpretation_comments":[],"record_status":"current","interpretation_description":"Uncertain significance","variation_id":"48176"}
{"id":"SCV001037250","clinical_assertion_trait_set_id":"SCV001037250","content":"{\"AttributeSet\":{\"Attribute\":{\"$\":\"Invitae Variant Classification Sherloc (09022015)\",\"@Type\":\"AssertionMethod\"},\"Citation\":{\"ID\":{\"$\":\"28492532\",\"@Source\":\"PubMed\"}}}}","submission_id":"500031.2020-01-29","interpretation_date_last_evaluated":"2019-12-31","version":"2","internal_id":"2005121","clinical_assertion_observation_ids":["SCV001037250.0"],"date_last_updated":"2020-05-04","assertion_type":"variation to disease","variation_archive_id":"VCV000007884","review_status":"criteria provided, single submitter","trait_set_id":"9460","date_created":"2019-12-11","submitter_id":"500031","rcv_accession_id":"RCV000078671","submission_names":["SUB6897608"],"local_key":"2281434|MedGen:CN517202","submitted_assembly":"GRCh37","interpretation_comments":[],"record_status":"current","interpretation_description":"Benign","variation_id":"7884"}
